The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transcriptomics Technologies Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Transcriptomics Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transcriptomics Technologies market size is estimated to be worth US$ 4205.2 million in 2021 and is forecast to a readjusted size of USD 7498.3 million by 2028 with a CAGR of 8.6% during review period. Clinical Diagnostics accounting for % of the Transcriptomics Technologies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Microarrays segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Transcriptomics Technologies include Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., and Illumina, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transcriptomics Technologies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microarrays
Polymerase Chain Reaction (PCR)
Gene Regulation Technologies
Next Generation Sequencing (NGS)
Market segment by Application, can be divided into
Clinical Diagnostics
Drug Discovery and Research
Bioinformatics
Comparative Transcriptomics Studies
Market segment by players, this report covers
Affymetrix, Inc.
Thermo Fisher Scientific
Agilent Technologies
F-Hoffmann La Roche Ltd.
Illumina, Inc.
Life Technologies Corporation
Qiangen N.V.
LC Sciences
Sigma-Aldrich Corp
Danaher Corp
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Transcriptomics Technologies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Transcriptomics Technologies, with revenue, gross margin and global market share of Transcriptomics Technologies from 2019 to 2022.
Chapter 3, the Transcriptomics Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Transcriptomics Technologies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Transcriptomics Technologies research findings and conclusion, appendix and data source.
Geographical Area
Global
The Transcriptomics Technologies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Transcriptomics Technologies market size is estimated to be worth US$ 4205.2 million in 2021 and is forecast to a readjusted size of USD 7498.3 million by 2028 with a CAGR of 8.6% during review period. Clinical Diagnostics accounting for % of the Transcriptomics Technologies global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Microarrays segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Transcriptomics Technologies include Affymetrix, Inc., Thermo Fisher Scientific, Agilent Technologies, F-Hoffmann La Roche Ltd., and Illumina, Inc., etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transcriptomics Technologies market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Microarrays
Polymerase Chain Reaction (PCR)
Gene Regulation Technologies
Next Generation Sequencing (NGS)
Market segment by Application, can be divided into
Clinical Diagnostics
Drug Discovery and Research
Bioinformatics
Comparative Transcriptomics Studies
Market segment by players, this report covers
Affymetrix, Inc.
Thermo Fisher Scientific
Agilent Technologies
F-Hoffmann La Roche Ltd.
Illumina, Inc.
Life Technologies Corporation
Qiangen N.V.
LC Sciences
Sigma-Aldrich Corp
Danaher Corp
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Transcriptomics Technologies product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Transcriptomics Technologies, with revenue, gross margin and global market share of Transcriptomics Technologies from 2019 to 2022.
Chapter 3, the Transcriptomics Technologies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Transcriptomics Technologies market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Transcriptomics Technologies research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Transcriptomics Technologies
1.2 Classification of Transcriptomics Technologies by Type
1.2.1 Overview: Global Transcriptomics Technologies Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Transcriptomics Technologies Revenue Market Share by Type in 2021
1.2.3 Microarrays
1.2.4 Polymerase Chain Reaction (PCR)
1.2.5 Gene Regulation Technologies
1.2.6 Next Generation Sequencing (NGS)
1.3 Global Transcriptomics Technologies Market by Application
1.3.1 Overview: Global Transcriptomics Technologies Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery and Research
1.3.4 Bioinformatics
1.3.5 Comparative Transcriptomics Studies
1.4 Global Transcriptomics Technologies Market Size & Forecast
1.5 Global Transcriptomics Technologies Market Size and Forecast by Region
1.5.1 Global Transcriptomics Technologies Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Transcriptomics Technologies Market Size by Region, (2017-2022)
1.5.3 North America Transcriptomics Technologies Market Size and Prospect (2017-2028)
1.5.4 Europe Transcriptomics Technologies Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Transcriptomics Technologies Market Size and Prospect (2017-2028)
1.5.6 South America Transcriptomics Technologies Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Transcriptomics Technologies Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Transcriptomics Technologies Market Drivers
1.6.2 Transcriptomics Technologies Market Restraints
1.6.3 Transcriptomics Technologies Trends Analysis
2 Company Profiles
2.1 Affymetrix, Inc.
2.1.1 Affymetrix, Inc. Details
2.1.2 Affymetrix, Inc. Major Business
2.1.3 Affymetrix, Inc. Transcriptomics Technologies Product and Solutions
2.1.4 Affymetrix, Inc. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Affymetrix, Inc. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Transcriptomics Technologies Product and Solutions
2.2.4 Thermo Fisher Scientific Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Agilent Technologies
2.3.1 Agilent Technologies Details
2.3.2 Agilent Technologies Major Business
2.3.3 Agilent Technologies Transcriptomics Technologies Product and Solutions
2.3.4 Agilent Technologies Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Agilent Technologies Recent Developments and Future Plans
2.4 F-Hoffmann La Roche Ltd.
2.4.1 F-Hoffmann La Roche Ltd. Details
2.4.2 F-Hoffmann La Roche Ltd. Major Business
2.4.3 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Product and Solutions
2.4.4 F-Hoffmann La Roche Ltd. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 F-Hoffmann La Roche Ltd. Recent Developments and Future Plans
2.5 Illumina, Inc.
2.5.1 Illumina, Inc. Details
2.5.2 Illumina, Inc. Major Business
2.5.3 Illumina, Inc. Transcriptomics Technologies Product and Solutions
2.5.4 Illumina, Inc. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Illumina, Inc. Recent Developments and Future Plans
2.6 Life Technologies Corporation
2.6.1 Life Technologies Corporation Details
2.6.2 Life Technologies Corporation Major Business
2.6.3 Life Technologies Corporation Transcriptomics Technologies Product and Solutions
2.6.4 Life Technologies Corporation Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Life Technologies Corporation Recent Developments and Future Plans
2.7 Qiangen N.V.
2.7.1 Qiangen N.V. Details
2.7.2 Qiangen N.V. Major Business
2.7.3 Qiangen N.V. Transcriptomics Technologies Product and Solutions
2.7.4 Qiangen N.V. Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Qiangen N.V. Recent Developments and Future Plans
2.8 LC Sciences
2.8.1 LC Sciences Details
2.8.2 LC Sciences Major Business
2.8.3 LC Sciences Transcriptomics Technologies Product and Solutions
2.8.4 LC Sciences Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 LC Sciences Recent Developments and Future Plans
2.9 Sigma-Aldrich Corp
2.9.1 Sigma-Aldrich Corp Details
2.9.2 Sigma-Aldrich Corp Major Business
2.9.3 Sigma-Aldrich Corp Transcriptomics Technologies Product and Solutions
2.9.4 Sigma-Aldrich Corp Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Sigma-Aldrich Corp Recent Developments and Future Plans
2.10 Danaher Corp
2.10.1 Danaher Corp Details
2.10.2 Danaher Corp Major Business
2.10.3 Danaher Corp Transcriptomics Technologies Product and Solutions
2.10.4 Danaher Corp Transcriptomics Technologies Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Danaher Corp Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Transcriptomics Technologies Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Transcriptomics Technologies Players Market Share in 2021
3.2.2 Top 10 Transcriptomics Technologies Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Transcriptomics Technologies Players Head Office, Products and Services Provided
3.4 Transcriptomics Technologies Mergers & Acquisitions
3.5 Transcriptomics Technologies New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Transcriptomics Technologies Revenue and Market Share by Type (2017-2022)
4.2 Global Transcriptomics Technologies Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Transcriptomics Technologies Revenue Market Share by Application (2017-2022)
5.2 Global Transcriptomics Technologies Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Transcriptomics Technologies Revenue by Type (2017-2028)
6.2 North America Transcriptomics Technologies Revenue by Application (2017-2028)
6.3 North America Transcriptomics Technologies Market Size by Country
6.3.1 North America Transcriptomics Technologies Revenue by Country (2017-2028)
6.3.2 United States Transcriptomics Technologies Market Size and Forecast (2017-2028)
6.3.3 Canada Transcriptomics Technologies Market Size and Forecast (2017-2028)
6.3.4 Mexico Transcriptomics Technologies Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Transcriptomics Technologies Revenue by Type (2017-2028)
7.2 Europe Transcriptomics Technologies Revenue by Application (2017-2028)
7.3 Europe Transcriptomics Technologies Market Size by Country
7.3.1 Europe Transcriptomics Technologies Revenue by Country (2017-2028)
7.3.2 Germany Transcriptomics Technologies Market Size and Forecast (2017-2028)
7.3.3 France Transcriptomics Technologies Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Transcriptomics Technologies Market Size and Forecast (2017-2028)
7.3.5 Russia Transcriptomics Technologies Market Size and Forecast (2017-2028)
7.3.6 Italy Transcriptomics Technologies Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Transcriptomics Technologies Revenue by Type (2017-2028)
8.2 Asia-Pacific Transcriptomics Technologies Revenue by Application (2017-2028)
8.3 Asia-Pacific Transcriptomics Technologies Market Size by Region
8.3.1 Asia-Pacific Transcriptomics Technologies Revenue by Region (2017-2028)
8.3.2 China Transcriptomics Technologies Market Size and Forecast (2017-2028)
8.3.3 Japan Transcriptomics Technologies Market Size and Forecast (2017-2028)
8.3.4 South Korea Transcriptomics Technologies Market Size and Forecast (2017-2028)
8.3.5 India Transcriptomics Technologies Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Transcriptomics Technologies Market Size and Forecast (2017-2028)
8.3.7 Australia Transcriptomics Technologies Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Transcriptomics Technologies Revenue by Type (2017-2028)
9.2 South America Transcriptomics Technologies Revenue by Application (2017-2028)
9.3 South America Transcriptomics Technologies Market Size by Country
9.3.1 South America Transcriptomics Technologies Revenue by Country (2017-2028)
9.3.2 Brazil Transcriptomics Technologies Market Size and Forecast (2017-2028)
9.3.3 Argentina Transcriptomics Technologies Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Transcriptomics Technologies Revenue by Type (2017-2028)
10.2 Middle East & Africa Transcriptomics Technologies Revenue by Application (2017-2028)
10.3 Middle East & Africa Transcriptomics Technologies Market Size by Country
10.3.1 Middle East & Africa Transcriptomics Technologies Revenue by Country (2017-2028)
10.3.2 Turkey Transcriptomics Technologies Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Transcriptomics Technologies Market Size and Forecast (2017-2028)
10.3.4 UAE Transcriptomics Technologies Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Transcriptomics Technologies Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Transcriptomics Technologies Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Transcriptomics Technologies Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Transcriptomics Technologies Revenue (USD Million) by Region (2017-2022)
Table 5. Global Transcriptomics Technologies Revenue Market Share by Region (2023-2028)
Table 6. Affymetrix, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Affymetrix, Inc. Major Business
Table 8. Affymetrix, Inc. Transcriptomics Technologies Product and Solutions
Table 9. Affymetrix, Inc. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Transcriptomics Technologies Product and Solutions
Table 13. Thermo Fisher Scientific Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 15. Agilent Technologies Major Business
Table 16. Agilent Technologies Transcriptomics Technologies Product and Solutions
Table 17. Agilent Technologies Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. F-Hoffmann La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 19. F-Hoffmann La Roche Ltd. Major Business
Table 20. F-Hoffmann La Roche Ltd. Transcriptomics Technologies Product and Solutions
Table 21. F-Hoffmann La Roche Ltd. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Illumina, Inc. Major Business
Table 24. Illumina, Inc. Transcriptomics Technologies Product and Solutions
Table 25. Illumina, Inc. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Life Technologies Corporation Corporate Information, Head Office, and Major Competitors
Table 27. Life Technologies Corporation Major Business
Table 28. Life Technologies Corporation Transcriptomics Technologies Product and Solutions
Table 29. Life Technologies Corporation Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Qiangen N.V. Corporate Information, Head Office, and Major Competitors
Table 31. Qiangen N.V. Major Business
Table 32. Qiangen N.V. Transcriptomics Technologies Product and Solutions
Table 33. Qiangen N.V. Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. LC Sciences Corporate Information, Head Office, and Major Competitors
Table 35. LC Sciences Major Business
Table 36. LC Sciences Transcriptomics Technologies Product and Solutions
Table 37. LC Sciences Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Sigma-Aldrich Corp Corporate Information, Head Office, and Major Competitors
Table 39. Sigma-Aldrich Corp Major Business
Table 40. Sigma-Aldrich Corp Transcriptomics Technologies Product and Solutions
Table 41. Sigma-Aldrich Corp Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Danaher Corp Corporate Information, Head Office, and Major Competitors
Table 43. Danaher Corp Major Business
Table 44. Danaher Corp Transcriptomics Technologies Product and Solutions
Table 45. Danaher Corp Transcriptomics Technologies Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Transcriptomics Technologies Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Transcriptomics Technologies Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Transcriptomics Technologies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Transcriptomics Technologies Players Head Office, Products and Services Provided
Table 50. Transcriptomics Technologies Mergers & Acquisitions in the Past Five Years
Table 51. Transcriptomics Technologies New Entrants and Expansion Plans
Table 52. Global Transcriptomics Technologies Revenue (USD Million) by Type (2017-2022)
Table 53. Global Transcriptomics Technologies Revenue Share by Type (2017-2022)
Table 54. Global Transcriptomics Technologies Revenue Forecast by Type (2023-2028)
Table 55. Global Transcriptomics Technologies Revenue by Application (2017-2022)
Table 56. Global Transcriptomics Technologies Revenue Forecast by Application (2023-2028)
Table 57. North America Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Transcriptomics Technologies Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Transcriptomics Technologies Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Transcriptomics Technologies Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Transcriptomics Technologies Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Transcriptomics Technologies Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Transcriptomics Technologies Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Transcriptomics Technologies Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Transcriptomics Technologies Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Transcriptomics Technologies Picture
Figure 2. Global Transcriptomics Technologies Revenue Market Share by Type in 2021
Figure 3. Microarrays
Figure 4. Polymerase Chain Reaction (PCR)
Figure 5. Gene Regulation Technologies
Figure 6. Next Generation Sequencing (NGS)
Figure 7. Transcriptomics Technologies Revenue Market Share by Application in 2021
Figure 8. Clinical Diagnostics Picture
Figure 9. Drug Discovery and Research Picture
Figure 10. Bioinformatics Picture
Figure 11. Comparative Transcriptomics Studies Picture
Figure 12. Global Transcriptomics Technologies Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Transcriptomics Technologies Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Transcriptomics Technologies Revenue Market Share by Region (2017-2028)
Figure 15. Global Transcriptomics Technologies Revenue Market Share by Region in 2021
Figure 16. North America Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Transcriptomics Technologies Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Transcriptomics Technologies Market Drivers
Figure 22. Transcriptomics Technologies Market Restraints
Figure 23. Transcriptomics Technologies Market Trends
Figure 24. Affymetrix, Inc. Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 26. Agilent Technologies Recent Developments and Future Plans
Figure 27. F-Hoffmann La Roche Ltd. Recent Developments and Future Plans
Figure 28. Illumina, Inc. Recent Developments and Future Plans
Figure 29. Life Technologies Corporation Recent Developments and Future Plans
Figure 30. Qiangen N.V. Recent Developments and Future Plans
Figure 31. LC Sciences Recent Developments and Future Plans
Figure 32. Sigma-Aldrich Corp Recent Developments and Future Plans
Figure 33. Danaher Corp Recent Developments and Future Plans
Figure 34. Global Transcriptomics Technologies Revenue Share by Players in 2021
Figure 35. Transcriptomics Technologies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 36. Global Top 3 Players Transcriptomics Technologies Revenue Market Share in 2021
Figure 37. Global Top 10 Players Transcriptomics Technologies Revenue Market Share in 2021
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 39. Global Transcriptomics Technologies Revenue Share by Type in 2021
Figure 40. Global Transcriptomics Technologies Market Share Forecast by Type (2023-2028)
Figure 41. Global Transcriptomics Technologies Revenue Share by Application in 2021
Figure 42. Global Transcriptomics Technologies Market Share Forecast by Application (2023-2028)
Figure 43. North America Transcriptomics Technologies Sales Market Share by Type (2017-2028)
Figure 44. North America Transcriptomics Technologies Sales Market Share by Application (2017-2028)
Figure 45. North America Transcriptomics Technologies Revenue Market Share by Country (2017-2028)
Figure 46. United States Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Transcriptomics Technologies Sales Market Share by Type (2017-2028)
Figure 50. Europe Transcriptomics Technologies Sales Market Share by Application (2017-2028)
Figure 51. Europe Transcriptomics Technologies Revenue Market Share by Country (2017-2028)
Figure 52. Germany Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Transcriptomics Technologies Sales Market Share by Type (2017-2028)
Figure 58. Asia-Pacific Transcriptomics Technologies Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Transcriptomics Technologies Revenue Market Share by Region (2017-2028)
Figure 60. China Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South Korea Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Transcriptomics Technologies Sales Market Share by Type (2017-2028)
Figure 67. South America Transcriptomics Technologies Sales Market Share by Application (2017-2028)
Figure 68. South America Transcriptomics Technologies Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East and Africa Transcriptomics Technologies Sales Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Transcriptomics Technologies Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Transcriptomics Technologies Revenue Market Share by Country (2017-2028)
Figure 74. Turkey Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. UAE Transcriptomics Technologies Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
